SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 26.10
  • 52 Week Low: 10.38
  • Currency: UK Pounds
  • Shares Issued: 258.78m
  • Volume: 0
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
98.50% above the market average98.50% above the market average98.50% above the market average98.50% above the market average98.50% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
68.89% above the market average68.89% above the market average68.89% above the market average68.89% above the market average68.89% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Price Book Ratio
94.75% below the market average94.75% below the market average94.75% below the market average94.75% below the market average94.75% below the market average
78.38% below the sector average78.38% below the sector average78.38% below the sector average78.38% below the sector average78.38% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
28.48% above the market average28.48% above the market average28.48% above the market average28.48% above the market average28.48% above the market average
24.44% above the sector average24.44% above the sector average24.44% above the sector average24.44% above the sector average24.44% above the sector average
Price Chg 3m
88.74% below the market average88.74% below the market average88.74% below the market average88.74% below the market average88.74% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
39.00% above the market average39.00% above the market average39.00% above the market average39.00% above the market average39.00% above the market average
31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average
Momentum 20
20.09% above the market average20.09% above the market average20.09% above the market average20.09% above the market average20.09% above the market average
26.83% above the sector average26.83% above the sector average26.83% above the sector average26.83% above the sector average26.83% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
84.71% below the market average84.71% below the market average84.71% below the market average84.71% below the market average84.71% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
63.13% below the market average63.13% below the market average63.13% below the market average63.13% below the market average63.13% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
78.98% below the market average78.98% below the market average78.98% below the market average78.98% below the market average78.98% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
Operating Profit Loss
64.16% below the market average64.16% below the market average64.16% below the market average64.16% below the market average64.16% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
74.76% below the market average74.76% below the market average74.76% below the market average74.76% below the market average74.76% below the market average
51.22% below the sector average51.22% below the sector average51.22% below the sector average51.22% below the sector average51.22% below the sector average
Cash
62.62% below the market average62.62% below the market average62.62% below the market average62.62% below the market average62.62% below the market average
48.84% below the sector average48.84% below the sector average48.84% below the sector average48.84% below the sector average48.84% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 17.00p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 26.10
52 Week Low 10.38
Volume 0
Shares Issued 258.78m
Beta 0.01

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average
90.7% below the sector average90.7% below the sector average90.7% below the sector average90.7% below the sector average90.7% below the sector average
Price Trend
48.75% above the market average48.75% above the market average48.75% above the market average48.75% above the market average48.75% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average
Income Not Available
Growth
49.76% above the market average49.76% above the market average49.76% above the market average49.76% above the market average49.76% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average

SBTX Dividends

No dividends found

Trades for 04-Aug-2025

Time Volume / Share Price
15:44 10,276 @ 16.66p
15:10 18,000 @ 16.89p
14:53 7,570 @ 16.65p
13:30 250,000 @ 16.63p
13:03 294 @ 17.00p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page